Arovella Therapeutics Ltd (ALA) - Total Liabilities

Latest as of December 2025: AU$1.33 Million AUD ≈ $940.32K USD

Based on the latest financial reports, Arovella Therapeutics Ltd (ALA) has total liabilities worth AU$1.33 Million AUD (≈ $940.32K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Arovella Therapeutics Ltd to assess how effectively this company generates cash.

Arovella Therapeutics Ltd - Total Liabilities Trend (2001–2025)

This chart illustrates how Arovella Therapeutics Ltd's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Arovella Therapeutics Ltd's assets to evaluate the company's liquid asset resilience ratio.

Arovella Therapeutics Ltd Competitors by Total Liabilities

The table below lists competitors of Arovella Therapeutics Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
EstechPharma Co. Ltd KQ:041910	Korea	₩60.00 Billion
Chang Type Industrial Co Ltd TW:1541	Taiwan	NT$1.26 Billion
Edelteq Holdings Berhad KLSE:0278	Malaysia	RM8.40 Million
PW Consolidated Bhd KLSE:7134	Malaysia	RM171.12 Million
ADVENICA AB F:65R	Germany	€85.34 Million
Hyundai HT CoLtd KQ:039010	Korea	₩31.05 Billion
Articore Group Ltd AU:ATG	Australia	AU$63.56 Million
An-Shin Food Services Co Ltd TWO:1259	Taiwan	NT$3.82 Billion

Liability Composition Analysis (2001–2025)

This chart breaks down Arovella Therapeutics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Arovella Therapeutics Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	15.00	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Arovella Therapeutics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Arovella Therapeutics Ltd (2001–2025)

The table below shows the annual total liabilities of Arovella Therapeutics Ltd from 2001 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$1.52 Million ≈ $1.08 Million	-25.89%
2024-06-30	AU$2.06 Million ≈ $1.46 Million	+21.63%
2023-06-30	AU$1.69 Million ≈ $1.20 Million	+5.99%
2022-06-30	AU$1.60 Million ≈ $1.13 Million	-6.46%
2021-06-30	AU$1.71 Million ≈ $1.21 Million	-33.69%
2020-06-30	AU$2.57 Million ≈ $1.82 Million	+13.02%
2019-06-30	AU$2.28 Million ≈ $1.61 Million	-56.04%
2018-06-30	AU$5.18 Million ≈ $3.66 Million	+63.68%
2017-06-30	AU$3.16 Million ≈ $2.24 Million	+8.73%
2016-06-30	AU$2.91 Million ≈ $2.06 Million	-17.35%
2015-06-30	AU$3.52 Million ≈ $2.49 Million	-19.18%
2014-06-30	AU$4.36 Million ≈ $3.08 Million	+7.84%
2013-06-30	AU$4.04 Million ≈ $2.86 Million	+47.27%
2012-06-30	AU$2.74 Million ≈ $1.94 Million	+9.98%
2011-06-30	AU$2.49 Million ≈ $1.76 Million	-29.89%
2010-06-30	AU$3.56 Million ≈ $2.52 Million	-54.22%
2009-06-30	AU$7.77 Million ≈ $5.50 Million	+39.87%
2008-06-30	AU$5.55 Million ≈ $3.93 Million	-16.74%
2007-06-30	AU$6.67 Million ≈ $4.72 Million	+103.52%
2006-06-30	AU$3.28 Million ≈ $2.32 Million	+1.58%
2005-06-30	AU$3.23 Million ≈ $2.28 Million	+14.40%
2004-06-30	AU$2.82 Million ≈ $2.00 Million	+218.60%
2003-06-30	AU$885.34K ≈ $626.43K	+505.38%
2002-06-30	AU$146.25K ≈ $103.48K	+3974.81%
2001-06-30	AU$3.59K ≈ $2.54K	--

About Arovella Therapeutics Ltd

AU:ALA Australia Biotechnology

Market Cap

$58.08 Million

AU$82.09 Million AUD

Market Cap Rank

#21314 Global

#753 in Australia

Share Price

AU$0.07

Change (1 day)

-2.86%

52-Week Range

AU$0.07 - AU$0.12

All Time High

AU$0.57